Kenvue Inc.

NYSE KVUE

Kenvue Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 29, 2024: 57.72%

Kenvue Inc. Gross Profit Margin is 57.72% for the Trailing 12 Months (TTM) ending September 29, 2024, a 3.12% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Kenvue Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 55.97%, a 1.63% change year over year.
  • Kenvue Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending October 02, 2022 was 55.08%.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
NYSE: KVUE

Kenvue Inc.

CEO Mr. Thibaut Mongon
IPO Date May 4, 2023
Location United States
Headquarters 199 Grandview Road
Employees 22,000
Sector Consumer Staples
Industries
Consumer Packaged Goods Cosmetics Personal Care
Description

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.

StockViz Staff

January 15, 2025

Any question? Send us an email